Anthem (NYSE:ANTM) had its target price increased by Morgan Stanley from $359.00 to $371.00 in a report published on Friday, BenzingaRatingsTable reports. Morgan Stanley currently has an overweight rating on the stock.
ANTM has been the topic of several other reports. Barclays lifted their price objective on T. Rowe Price Group from $90.00 to $95.00 and gave the company an underweight rating in a research note on Thursday, April 25th. Citigroup reaffirmed a buy rating on shares of Healthequity in a research note on Friday, May 10th. Cantor Fitzgerald reaffirmed a buy rating and issued a $75.00 price objective on shares of Emergent Biosolutions in a research note on Sunday, April 21st. Zacks Investment Research lowered G1 Therapeutics from a buy rating to a hold rating in a research note on Thursday, May 16th. Finally, SunTrust Banks reiterated a hold rating and set a $44.00 target price on shares of Shutterstock in a report on Thursday, April 25th. Two research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. The company currently has an average rating of Buy and an average price target of $325.67.
NYSE ANTM opened at $306.85 on Friday. The firm has a market cap of $78.92 billion, a price-to-earnings ratio of 19.31, a P/E/G ratio of 1.10 and a beta of 0.70. Anthem has a 1-year low of $227.16 and a 1-year high of $317.99. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.58. The company has a 50-day moving average price of $285.29.
The business also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 10th were issued a dividend of $0.80 per share. The ex-dividend date of this dividend was Friday, June 7th. This represents a $3.20 annualized dividend and a dividend yield of 1.04%. Anthem’s payout ratio is currently 20.14%.
In other Anthem news, SVP Ronald W. Penczek sold 763 shares of Anthem stock in a transaction that occurred on Thursday, May 30th. The stock was sold at an average price of $279.00, for a total transaction of $212,877.00. Following the sale, the senior vice president now directly owns 2,295 shares in the company, valued at approximately $640,305. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Ramiro G. Peru sold 1,656 shares of Anthem stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $275.00, for a total value of $455,400.00. Following the sale, the director now owns 11,173 shares in the company, valued at $3,072,575. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 11,245 shares of company stock worth $3,174,155. Company insiders own 0.17% of the company’s stock.
A number of hedge funds have recently bought and sold shares of ANTM. Norges Bank purchased a new stake in Anthem during the 4th quarter worth approximately $667,351,000. CI Investments Inc. increased its holdings in shares of Anthem by 373.8% in the 4th quarter. CI Investments Inc. now owns 1,241,273 shares of the company’s stock valued at $325,995,000 after acquiring an additional 979,273 shares during the last quarter. Egerton Capital UK LLP increased its holdings in shares of Anthem by 176.8% in the 1st quarter. Egerton Capital UK LLP now owns 694,185 shares of the company’s stock valued at $199,217,000 after acquiring an additional 443,428 shares during the last quarter. NN Investment Partners Holdings N.V. increased its holdings in shares of Anthem by 252.0% in the 2nd quarter. NN Investment Partners Holdings N.V. now owns 523,468 shares of the company’s stock valued at $147,728,000 after acquiring an additional 374,746 shares during the last quarter. Finally, Marshall Wace North America L.P. increased its holdings in shares of Anthem by 1,493.8% in the 1st quarter. Marshall Wace North America L.P. now owns 371,175 shares of the company’s stock valued at $106,520,000 after acquiring an additional 347,887 shares during the last quarter. Institutional investors own 87.09% of the company’s stock.
Anthem Company Profile
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets.
Featured Story: Outstanding Shares and The Effect on Share Price
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.